三尖瓣反流进展的决定因素及其对充分管理的意义
前瞻性随访1843例至少中度三尖瓣反流患者,中位2.3年随访中19%出现进展;基线中度三尖瓣反流患者1年、2年、3年进展率分别为4.9%、10.1%、24.8%。年龄较大、体重指数较低、慢性肾病、NYHA功能分级较差和右心室扩张与三尖瓣反流进展独立相关;进展与心血管死亡和心力衰竭住院增加相关(P<0.001)。
要点
- 至少中度三尖瓣反流患者中位2.3年随访19%出现进展,基线中度者3年进展率达24.8%。
- 年龄较大、体重指数较低、慢性肾病、NYHA功能分级较差、右心室扩张与三尖瓣反流进展独立相关。
- 三尖瓣反流进展与心血管死亡和心力衰竭住院增加相关(P<0.001),无论初始反流严重程度如何。
核心结论
- 三尖瓣反流进展存在明显的个体差异,妨碍了准确的随访;无论初始三尖瓣反流严重程度如何,三尖瓣反流进展均是生存的决定因素。
研究设计与样本
- 前瞻性研究,共纳入1843例至少中度三尖瓣反流患者,连续进行超声心动图研究和/或临床评估随访,随访不足2年者被排除;记录临床和超声心动图特征、心力衰竭住院、心血管死亡和干预措施以评估其对三尖瓣反流进展的影响。
关键影像表现/征象
- 中位2.3年随访期间19%的患者出现三尖瓣反流进展。
- 基线中度三尖瓣反流患者1年、2年、3年进展率分别为4.9%、10.1%、24.8%。
- 三尖瓣反流进展与心腔扩张增加、心室-动脉耦联降低及左心室射血分数降低相关(P<0.001)。
诊断标准与关键数值
- 三尖瓣反流进展的独立相关因素:年龄较大(HR:1.03)、体重指数较低(HR:0.95)、慢性肾病(HR:1.55)、NYHA功能分级较差(HR:1.52)、右心室扩张(HR:1.33)。
临床应用与阅片要点
- 三尖瓣反流进展与心血管死亡和心力衰竭住院增加相关(P<0.001)。
- 三尖瓣反流进展存在明显个体差异,可能妨碍准确的随访。
局限性
- 三尖瓣反流的自然病史证据缺乏,尤其是进展的变化模式和临床影响方面。
- 随访不足2年的患者被排除。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
BACKGROUND: Tricuspid regurgitation (TR) is associated with an increased mortality. Previous studies have analyzed predictors of TR progression and the clinical impact of baseline TR. However, there is a lack of evidence regarding the natural history of TR: the pattern of change and clinical impact of progression.
OBJECTIVES: The authors sought to evaluate predictors of TR progression and assess the prognostic impact of TR progression.
METHODS: A total of 1,843 patients with at least moderate TR were prospectively followed up with consecutive echocardiographic studies and/or clinical evaluation. All patients with less than a 2-year follow-up were excluded. Clinical and echocardiographic features, hospitalizations for heart failure, and cardiovascular death and interventions were recorded to assess their impact in TR progression.
RESULTS: At a median 2.3-year follow-up, 19% of patients experienced progression. Patients with baseline moderate TR presented a rate progression of 4.9%, 10.1%, and 24.8% 1 year, 2 years, and 3 years, respectively. Older age (HR: 1.03), lower body mass index (HR: 0.95), chronic kidney disease (HR: 1.55), worse NYHA functional class (HR: 1.52), and right ventricle dilation (HR: 1.33) were independently associated with TR progression. TR progression was associated with an increase in chamber dilation as well as a decrease in ventriculoarterial coupling and in left ventricle ejection fraction (P < 0.001). TR progression was associated with an increased cardiovascular mortality and hospitalizations for heart failure (P < 0.001).
CONCLUSIONS: Marked individual variability in TR progression hindered accurate follow-up. In addition, TR progression was a determinant for survival regardless of initial TR severity.
引用
- Arteagoitia Bolumburu A, Monteagudo Ruiz JM, Mahia P, et al. Determinants of Tricuspid Regurgitation Progression and Its Implications for Adequate Management. JACC Cardiovasc Imaging. 2023. PMID: 38069980. doi:10.1016/j.jcmg.2023.10.006
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。